Table 2 Trends in BP and cholesterol measurements between 2008 and 2018
Annual measurements (2008–2018)
BPCholesterol
CVD and DM (%)68.5–78.7 (P<0.001)57.9–69.6 (P<0.001)
DM only (%)61.5–73.3 (P = 0.002)56.8–65.8 (P = 0.001)
CVD only (%)37.0–48.4 (P<0.001)25.8–40.2 (P<0.001)
Indication for CRA (%)33.0–31.9 (P = 0.37)25.7–27.7 (P = 0.43)
No indication for CRA (%)4.7–6.2 (P = 0.034)4.3–3.9 (P = 0.53)
Measurements every 2 years (2009–2010 and 2017–2018)
BPCholesterol
CVD and DM (%)80.8–87.6 (P<0.001)75.9–82.7 (P<0.001)
DM only (%)76.2–82.2 (P = 0.006)73.2–79.3 (P<0.001)
CVD only (%)54.5–64.2 (P<0.001)45.7–56.8 (P<0.001)
Indication for CRA (%)47.0–45.8 (P = 0.99)41.7–41.1 (P = 0.85)
No indication for CRA (%)9.2–11.1 (P = 0.36)8.0–7.4 (P = 0.12)
Measurements every 5 years (2009–2013 and 2014–2018)
BPCholesterol
CVD and DM (%)93.2–93.7 (P = 0.073)88.1–89.1 (P = 0.082)
DM only (%)88.5–88.9 (P = 0.65)84.8–85.8 (P = 0.057)
CVD only (%)78.6–81.2 (P<0.001)70.6–74.2 (P = 0.002)
Indication for CRA (%)68.5–66.2 (P = 0.023)62.7–60.5 (P = 0.009)
No indication for CRA (%)19.6–22.4 (P = 0.10)16.3–16.0 (P = 0.12)
  • Patients were classified as ‘Indication for CRA’ if they did not have a history of CVD or DM, but did have a history of one of the following: rheumatoid arthritis, pre-eclampsia, pregnancy-induced DM, family history of CVD, obesity, smoking, hypertension, dyslipidaemia, chronic kidney disease, use of antihypertensive or lipid-lowering medication.

  • BP = blood pressure. CRA = cardiovascular risk assessment. CVD = cardiovascular disease.